These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
843 related items for PubMed ID: 24413974
1. Self-assembly of virus-like particles of canine parvovirus capsid protein expressed from Escherichia coli and application as virus-like particle vaccine. Xu J, Guo HC, Wei YQ, Dong H, Han SC, Ao D, Sun DH, Wang HM, Cao SZ, Sun SQ. Appl Microbiol Biotechnol; 2014 Apr; 98(8):3529-38. PubMed ID: 24413974 [Abstract] [Full Text] [Related]
8. Display of neutralizing epitopes of Canine parvovirus and a T-cell epitope of the fusion protein of Canine distemper virus on chimeric tymovirus-like particles and its use as a vaccine candidate both against Canine parvo and Canine distemper. Chandran D, Shahana PV, Rani GS, Sugumar P, Shankar CR, Srinivasan VA. Vaccine; 2009 Dec 10; 28(1):132-9. PubMed ID: 19818723 [Abstract] [Full Text] [Related]
9. Molecular typing of canine parvovirus strains circulating from 2008 to 2012 in an organized kennel in India reveals the possibility of vaccination failure. Mittal M, Chakravarti S, Mohapatra JK, Chug PK, Dubey R, Upmanuyu V, Narwal PS, Kumar A, Churamani CP, Kanwar NS. Infect Genet Evol; 2014 Apr 10; 23():1-6. PubMed ID: 24486948 [Abstract] [Full Text] [Related]
11. High-yield production of canine parvovirus virus-like particles in a baculovirus expression system. Jin H, Xia X, Liu B, Fu Y, Chen X, Wang H, Xia Z. Arch Virol; 2016 Mar 10; 161(3):705-10. PubMed ID: 26666439 [Abstract] [Full Text] [Related]
12. In silico designing of multi-epitope vaccine against canine parvovirus using reverse vaccinology. Lopes TS, Gheno BP, Miranda LDS, Detofano J, Khan MAA, Streck AF. Braz J Microbiol; 2024 Sep 10; 55(3):2953-2968. PubMed ID: 39060911 [Abstract] [Full Text] [Related]
13. Canine parvovirus type 2 vaccine protects against virulent challenge with type 2c virus. Spibey N, Greenwood NM, Sutton D, Chalmers WS, Tarpey I. Vet Microbiol; 2008 Apr 01; 128(1-2):48-55. PubMed ID: 18006253 [Abstract] [Full Text] [Related]
14. Faecal shedding of canine parvovirus after modified-live vaccination in healthy adult dogs. Freisl M, Speck S, Truyen U, Reese S, Proksch AL, Hartmann K. Vet J; 2017 Jan 01; 219():15-21. PubMed ID: 28093104 [Abstract] [Full Text] [Related]
15. Vaccination with canine parvovirus type 2 (CPV-2) protects against challenge with virulent CPV-2b and CPV-2c. Siedek EM, Schmidt H, Sture GH, Raue R. Berl Munch Tierarztl Wochenschr; 2011 Jan 01; 124(1-2):58-64. PubMed ID: 21306055 [Abstract] [Full Text] [Related]
16. Inactivated recombinant plant virus protects dogs from a lethal challenge with canine parvovirus. Langeveld JP, Brennan FR, Martínez-Torrecuadrada JL, Jones TD, Boshuizen RS, Vela C, Casal JI, Kamstrup S, Dalsgaard K, Meloen RH, Bendig MM, Hamilton WD. Vaccine; 2001 Jun 14; 19(27):3661-70. PubMed ID: 11395200 [Abstract] [Full Text] [Related]
17. Vaccination of dogs with canine parvovirus type 2b (CPV-2b) induces neutralising antibody responses to CPV-2a and CPV-2c. Wilson S, Illambas J, Siedek E, Stirling C, Thomas A, Plevová E, Sture G, Salt J. Vaccine; 2014 Sep 22; 32(42):5420-4. PubMed ID: 25148778 [Abstract] [Full Text] [Related]
18. Evaluation of Chicken IgY Generated Against Canine Parvovirus Viral-Like Particles and Development of Enzyme-Linked Immunosorbent Assay and Immunochromatographic Assay for Canine Parvovirus Detection. He J, Wang Y, Sun S, Zhang X. Viral Immunol; 2015 Nov 22; 28(9):489-94. PubMed ID: 26469376 [Abstract] [Full Text] [Related]
20. No evidence for a role of modified live virus vaccines in the emergence of canine parvovirus. Truyen U, Geissler K, Parrish CR, Hermanns W, Siegl G. J Gen Virol; 1998 May 22; 79 ( Pt 5)():1153-8. PubMed ID: 9603330 [Abstract] [Full Text] [Related] Page: [Next] [New Search]